Intuitive Venture Partners | Venture Capital Firms NYC | Investment Bank New York City
Transactions News Contact Login
The FIRM Testimonials
Managing Partners Business Relationships
Investment Banking Services Proprietary Investment Opportunities
About The FIRM Testimonials Transactions Team Managing Partners Business Relationships Services Investment Banking Services Proprietary Investment Opportunities NewsContactLogin
Intuitive Venture Partners | Venture Capital Firms NYC | Investment Bank New York City
Ionetix Announces Approval of Abbreviated New Drug Application for Gallium Ga-68 Gozetotide (PSMA-11)
Intuitive Venture PartnersJune 2, 20262026, ionetix
Facebook0 Twitter LinkedIn0 Reddit Tumblr 0 Likes
Previous

Advanced Nuclear Company Deep Fission Announces Pricing of Public Offering of Common Stock

Intuitive Venture PartnersJune 20, 2026Deep Fission, 2026
Next

Aeluma Sees Accelerated Timeline for Quantum Commercialization

Intuitive Venture PartnersMay 28, 20262026, aeluma

Intuitive Venture Partners, LLC. • 777 Westchester Ave, Suite 101 • White Plains, NY 10604

Intuitive Venture Partners
777 Westchester Avenue,
White Plains, NY, 10604,
United States
212-612-3221 info@intuitivevp.com
Hours
Mon 8am - 5pm
Tue 8am - 5pm
Wed 8am - 5pm
Thu 8am - 5pm
Fri 8am - 5pm
 

2023 INTUITIVE VENTURE PARTNERS, LLC. ALL RIGHTS RESERVED. SECURITIES OFFERED THROUGH
NETWORK 1 FINANCIAL SECURITIES, INC., A REGISTERED BROKER-DEALER, MEMBER FINRA AND SIPC

broker-check-sml.png
Terms of UseContact